Effect of cetrorelix dose on premature LH surge during ovarian stimulation

Yu Hung Lin, K. M. Seow, H. J. Chen, B. C. Hsieh, L. W. Huang, C. R. Tzeng, Jiann-Loung Hwang

研究成果: 雜誌貢獻文章同行評審

7 引文 斯高帕斯(Scopus)

摘要

Previous studies have shown that ovarian stimulation with clomiphene citrate (CC), human menopausal gonadotrophin (HMG), and multiple-dose gonadotrophin-releasing hormone (GnRH) antagonist is associated with a high rate of premature LH surge. This study assessed whether administration of the GnRH antagonist cetrorelix at an incremental dose or at a high dose (0.5mg) from the start could prevent premature LH surge. Couples with male factor or unexplained infertility who were going to undergo intrauterine insemination were randomized into two stimulation protocols. All women were stimulated with CC and HMG. In protocol A, cetrorelix was given at 0.25 mg per day when the leading follicles reached 14 mm, and increased to 0.5 mg when the leading follicles were 16 mm. With protocol B, cetrorelix was given at 0.5 mg per day when the leading follicles reached 14 mm. The primary outcome measure was the incidence of premature LH surge. Premature LH surge occurred in 21.6% of patients undergoing protocol A, and in 18.9% of patients undergoing protocol B. Cetrorelix at incremental dose or at 0.5 mg per day does not prevent premature LH surges associated with the CC/ HMG/multiple-dose cetrorelix stimulation protocol.
原文英語
頁(從 - 到)772-777
頁數6
期刊Reproductive BioMedicine Online
16
發行號6
DOIs
出版狀態已發佈 - 六月 2008

ASJC Scopus subject areas

  • 生殖醫學
  • 婦產科
  • 發展生物學

指紋

深入研究「Effect of cetrorelix dose on premature LH surge during ovarian stimulation」主題。共同形成了獨特的指紋。

引用此